Year: 1998
Type: conference-abstract
Abstract: LilIy-SAT2.Zyprexa: New advances in the management of bipolar disorders 219s ventricular brain ratio) may be more pronounced in patients who have delayed onset of treatment.Finally, there is the issue of compliance.It has been repeatedly demonstrated that multiple relapses are detrimental to the course of illness.Enhancing treatment compliance, particularly in young schizophrenic patients, may be essential in determining the course of illness.Side effects are a major cause of noncompliance in schizophrenic patients.Therefore, new medications that are better tolerated than the typical antipsychotics may be important assets that the physician can use to improve the course of illness in schizophrenia.
Source: European Psychiatry
Author: David Pickar
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2076387832
